Efficacy of Pelvisoft® Biomesh for cystocele repair: assessment of long-term results
Introduction and Hypothesis To our knowledge a study regarding the efficacy of Pelvisoft® Biomesh for cystocele repair has not previously been reported in the literature. The aim of our study was to assess the long-term efficacy, subjective outcomes and complications in the...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sociedade Brasileira de Urologia
2014-12-01
|
| Series: | International Brazilian Journal of Urology |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382014000600828&lng=en&tlng=en |
| _version_ | 1811254922102964224 |
|---|---|
| author | Erwann Le Long John David Rebibo Romain Caremel Philippe Grise |
| author_facet | Erwann Le Long John David Rebibo Romain Caremel Philippe Grise |
| author_sort | Erwann Le Long |
| collection | DOAJ |
| description | Introduction and Hypothesis To our knowledge a study regarding the efficacy of Pelvisoft® Biomesh for cystocele repair has not previously been reported in the literature. The aim of our study was to assess the long-term efficacy, subjective outcomes and complications in the use of a non-synthetic porcine skin mesh graft (Pelvisoft® Biomesh) associated with transvaginal anterior colporrhaphy in the treatment of cystocele prolapse. Materials and Methods A retrospective study was performed at a single centre. Thirty-three women aged 35-77 years underwent cystocele repair using Pelvisoft® graft between December 2005 and June 2009. Twenty-nine women who underwent transvaginal cystocele repair with Pelvisoft® Biomesh for over a 2 years period were assessed. Four patients were lost to follow-up. Cystocele repair was performed via the vaginal route using Pelvisoft®Biomesh implant by inserting it in the anterior vaginal wall. The median follow-up time was 54.0 months. The rate of recurrence was 17.3%. A total of 6.9% of patients presented early mesh exposure treated by conservative treatment. The mean PFDI-20 score was 72.2. Among sexually active women, the mean PISQ 12 was 33.9 but 56.2% had dyspareunia. After surgery, 6 patients had de novo intercourse. Our results show that the use of Pelvisoft® biomaterial associated with anterior colporrhaphy for cystocele repair appears to be safe with acceptable failure and complication rates at long term. Nevertheless, an adverse impact on sexual function was reported by the majority of patients. |
| first_indexed | 2024-04-12T17:14:49Z |
| format | Article |
| id | doaj.art-4a963c1f7512461fa0b76c2d4f5e2270 |
| institution | Directory Open Access Journal |
| issn | 1677-6119 |
| language | English |
| last_indexed | 2024-04-12T17:14:49Z |
| publishDate | 2014-12-01 |
| publisher | Sociedade Brasileira de Urologia |
| record_format | Article |
| series | International Brazilian Journal of Urology |
| spelling | doaj.art-4a963c1f7512461fa0b76c2d4f5e22702022-12-22T03:23:40ZengSociedade Brasileira de UrologiaInternational Brazilian Journal of Urology1677-61192014-12-0140682883410.1590/S1677-5538.IBJU.2014.06.15S1677-55382014000600828Efficacy of Pelvisoft® Biomesh for cystocele repair: assessment of long-term resultsErwann Le LongJohn David RebiboRomain CaremelPhilippe GriseIntroduction and Hypothesis To our knowledge a study regarding the efficacy of Pelvisoft® Biomesh for cystocele repair has not previously been reported in the literature. The aim of our study was to assess the long-term efficacy, subjective outcomes and complications in the use of a non-synthetic porcine skin mesh graft (Pelvisoft® Biomesh) associated with transvaginal anterior colporrhaphy in the treatment of cystocele prolapse. Materials and Methods A retrospective study was performed at a single centre. Thirty-three women aged 35-77 years underwent cystocele repair using Pelvisoft® graft between December 2005 and June 2009. Twenty-nine women who underwent transvaginal cystocele repair with Pelvisoft® Biomesh for over a 2 years period were assessed. Four patients were lost to follow-up. Cystocele repair was performed via the vaginal route using Pelvisoft®Biomesh implant by inserting it in the anterior vaginal wall. The median follow-up time was 54.0 months. The rate of recurrence was 17.3%. A total of 6.9% of patients presented early mesh exposure treated by conservative treatment. The mean PFDI-20 score was 72.2. Among sexually active women, the mean PISQ 12 was 33.9 but 56.2% had dyspareunia. After surgery, 6 patients had de novo intercourse. Our results show that the use of Pelvisoft® biomaterial associated with anterior colporrhaphy for cystocele repair appears to be safe with acceptable failure and complication rates at long term. Nevertheless, an adverse impact on sexual function was reported by the majority of patients.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382014000600828&lng=en&tlng=enCystoceleBiocompatible MaterialsProlapse |
| spellingShingle | Erwann Le Long John David Rebibo Romain Caremel Philippe Grise Efficacy of Pelvisoft® Biomesh for cystocele repair: assessment of long-term results International Brazilian Journal of Urology Cystocele Biocompatible Materials Prolapse |
| title | Efficacy of Pelvisoft® Biomesh for cystocele repair: assessment of long-term results |
| title_full | Efficacy of Pelvisoft® Biomesh for cystocele repair: assessment of long-term results |
| title_fullStr | Efficacy of Pelvisoft® Biomesh for cystocele repair: assessment of long-term results |
| title_full_unstemmed | Efficacy of Pelvisoft® Biomesh for cystocele repair: assessment of long-term results |
| title_short | Efficacy of Pelvisoft® Biomesh for cystocele repair: assessment of long-term results |
| title_sort | efficacy of pelvisoft r biomesh for cystocele repair assessment of long term results |
| topic | Cystocele Biocompatible Materials Prolapse |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382014000600828&lng=en&tlng=en |
| work_keys_str_mv | AT erwannlelong efficacyofpelvisoftbiomeshforcystocelerepairassessmentoflongtermresults AT johndavidrebibo efficacyofpelvisoftbiomeshforcystocelerepairassessmentoflongtermresults AT romaincaremel efficacyofpelvisoftbiomeshforcystocelerepairassessmentoflongtermresults AT philippegrise efficacyofpelvisoftbiomeshforcystocelerepairassessmentoflongtermresults |